ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Stemedica Opens Enrollment in Phase II Clinical Trial for COVID-19
August 06, 2021Stemedica announces enrollment of patients for its study entitled "A Phase II, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Moderate. -
Stemedica Cell Technologies Reports Positive Data in Allogeneic Stem Cells Study
January 09, 2019Stemedica Cell Technologies announced positive results from its Phase I/IIa clinical study for the treatment of ischemic stroke.....
Pharma Sources Insight January 2025
